MOMarit Otto

Marit Otto

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Marit Otto has a total of 62 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Self-applied single-channel mastoid ExG for fully automated detection of REM sleep behaviour disorder

    by Casper Skjaerbaek, Andreas Tind Damgaard, Natasha Becker Bertelsen, Thea Pinholt Lillethorup, Jacob Horsager, Victoria Lowe, Naja Helt Andersen, Astrid Juhl Terkelsen, Marit Otto, David Bertram, et al.

    Isolated REM sleep behaviour disorder (RBD) is the strongest prodromal marker of Parkinson's disease (PD) and dementia with Lewy bodies, yet diagnosis requires video-polysomnography with assisted montage and expert scoring and does not scale to screening or trial enrichment. We developed a fully automated, self-applied system that detects RBD from a pair of electrodes placed behind the ears, with no manual scoring at any stage. A novel bipolar mastoid ExG derivation enables both sleep staging and quantification of REM sleep without atonia (RWA). A fine-tuned deep-learning 1-channel model staged sleep at a Cohen's kappa of 0.65 in PD, iRBD and controls (κ = 0.73 for the 2-channel model). Automated mastoid RWA correlated strongly with expert chin SINBAR scoring (r = 0.82). In self-applied home recordings from 76 participants, the 1-channel system detected RBD with an AUC of 0.95 (sensitivity 94%, specificity 86%), reproduced on in-lab polysomnographies (AUC 0.93, n = 378). In RBD, between-night RWA variability warrants repeated nights for prognostic monitoring. The system provides a scalable tool for RBD detection and a continuous RWA measure for longitudinal studies of neurodegeneration.

  • Open Access

    Central and peripheral excitability in restless limbs syndrome

    by Amedeo De Grado, Gaia Fanella, James Howells, Benjamin Yamin Ali Khan, Anna Bystrup Jacobsen, Bülent Cengiz, Gintaute Samusyte, Marit Otto, Paola Lanteri, Ambra Stefani, et al.

    Restless limbs syndrome (RLS) is a neurological disorder characterized by an uncontrollable urge to move the limbs. Although it affects up to 10% of the general population, its underlying mechanisms remain poorly understood. Neurophysiological excitability testing may help elucidate mechanisms related to sensorimotor integration, axonal ion channel dysfunction and impaired neural inhibition. This study aimed to assess both CNS and PNS function by examining cortical, spinal and peripheral nerve excitability within the same individuals for the first time. To investigate potential widespread excitability changes in RLS, we specifically analysed hand muscles, offering new insights into the extent of neural involvement beyond the lower limbs. The study included 56 RLS patients, divided into treated and untreated groups, along with 32 healthy controls. Notably, none of the patients experienced symptoms in their hands. Cortical excitability was assessed via threshold-tracking transcranial magnetic stimulation (TMS) to evaluate intracortical inhibition and facilitation. Sensory-motor integration was measured via long-latency reflexes (LLRs), while spinal cord excitability was assessed using F-waves, H-reflexes and RIII-reflexes. Axonal excitability was examined using the extended TRONDNF protocol. TMS revealed a significant reduction in short-interval intracortical inhibition (SICI) in patients, particularly at inter-stimulus intervals (ISIs) of 2.5 and 3 ms. When averaging across ISIs from 1 to 7 ms, patients on medication exhibited significantly less inhibition compared to healthy controls. Long-interval intracortical inhibition (LICI) was also reduced at ISIs of 150 and 200 ms, while facilitation parameters remained within normal ranges. Patients exhibited increased amplitude of the second component of the LLR recorded from the abductor pollicis brevis, whereas RIII reflex measurements showed no significant differences. Axonal excitability testing revealed a graded increase in hyperpolarization-activated currents in patients with more severe symptoms. The observed reductions in SICI and LICI suggest impaired intracortical inhibition in the M1 hand area, offering indirect evidence of cortical dysfunction in regions clinically unaffected by the disease. The increased LLR amplitudes further indicate altered sensorimotor integration at the cortical level, whereas the absence of significant changes in RIII reflexes suggests that segmental spinal dysfunction within the pain pathway of the upper limbs is unlikely. Finally, axonal excitability findings point to a potential role of hyperpolarization-activated currents in either contributing to or predisposing individuals to RLS symptoms.


  • Open Access

    Stroke Survivors’ Experiences of Sleep: A Hermeneutic Phenomenological Study

    by Ida Kathrine Westh, Louise Abildgaard Moeller, Marit Otto, Pia Dreyer, Grethe Andersen, Janne Kaergaard Mortensen

    Aim: To gain new insights into the lived experience of poststroke sleep. Design: Qualitative interview study. Methods: The study was based on a phenomenological‐hermeneutic approach inspired by the French Philosopher Paul Ricoeur. Fifteen participants were included between 2021 and 2022 and interviewed 3 months after stroke. Interviews were interpreted through naïve reading and structurally analyzed. Credibility was enhanced by investigator triangulation, and field notes were used for reflections during the interpretation process to challenge preconceptions. Results: The participants experienced changes in sleep and described a fear of lying awake at night. They described a lack of energy and a heavy body and mind as well as an overwhelming sleepiness during daytime. Three themes were identified through the analyses: “Floating through the night—a mental state of mind being between awake and asleep,” “Left with a heavy and slow feeling—poor sleep leads to a lack of energy,” and “Sleeping during daytime may happen like lightning from a clear sky.” Conclusions: The participants experienced frequent and substantial changes in sleep which affected their everyday lives in various ways.

  • Open Access

    Fatigue and Sleepiness in Multiple Sclerosis and Their Response to Short‐Term Treatment With Modafinil

    by Ann-Katrine Roswalld Thomsen, Marit Otto, Thor Petersen, Kristina Bacher Svendsen

    Background: Patients with multiple sclerosis (pwMS) often experience significant fatigue. Simultaneously, previous studies show that pwMS frequently suffer from sleepiness and sleep problems. We aimed to contribute to the understanding of correlations between sleep and sleepiness/fatigue in pwMS to better identify responders to the wake‐inducing drug, modafinil. Methods: This open‐label, two‐centre study included 26 pwMS suffering from daytime tiredness. Sleepiness, fatigue, and sleep were evaluated by questionnaires (Epworth Sleepiness Scale [ESS], Modified Fatigue Impact Scale [MFIS]/Multidimensional Fatigue Inventory [MFI‐20], and Pittsburgh), daily sleep diary, and a wrist‐worn actigraph before and after 3‐week modafinil treatment. Results: One‐third of the pwMS fulfilled the criteria of excessive daytime sleepiness (EDS, defined as ESS ≥ 10). Eighty‐two percent (MFIS) of the patients were fatigued, and a high proportion (96%) of the pwMS were poor sleepers. Sleepiness (ESS) was inverse correlated to the subjective sleep quality. Actigraph data did not relate to subjective sleep, but total sleep time (TST) and higher sleep efficacy (SE) estimated by actigraph were positively correlated to the degree of fatigue. Modafinil had a positive effect on EDS. Discussion: In the present study, we found that the tired multiple sclerosis (MS) patient may suffer from both EDS and fatigue. We found an inverse correlation between EDS and subjective sleep quality. On the contrary, fatigue was positively correlated with longer TST and higher SE, estimated by actigraph. Sleepiness and fatigue did not correlate, and thus, it is highly relevant to distinguish these two symptoms. Modafinil only showed an effect on fatigue when the patient also suffered from EDS, which could suggest that ESS is a possible screening tool for responders to modafinil treatment. Conclusion: Sleepiness and fatigue do not seem to correlate in pwMS, and we recommend screening tools for sleepiness as well as sleep quality before initiating modafinil treatment to identify potential responders to the treatment.


  • Monocyte markers correlate with immune and neuronal brain changes in REM sleep behavior disorder

    by Kristine Farmen, Sara K. Nissen, Morten G. Stokholm, Alex Iranzo, Karen Østergaard, Mónica Serradell, Marit Otto, Kristina B. Svendsen, Alicia Garrido, Dolores Vilas, et al.

    Synucleinopathies are neurodegenerative diseases with both central and peripheral immune responses. However, whether the peripheral immune changes occur early in disease and their relation to brain events is yet unclear. Isolated rapid-eye-movement (REM) sleep behavior disorder (iRBD) can precede synucleinopathy-related parkinsonism and provides a prodromal phenotype to study early Parkinson9s disease events. In this prospective case-control study, we describe monocytic markers in a cohort of iRBD patients that were associated with the brain-imaging markers of inflammation and neuronal dysfunction. Using 11C-PK11195 positron emission tomography (PET), we previously showed increased immune activation in the substantia nigra of iRBD patients, while 18F-DOPA PET detected reduced putaminal dopaminergic function. Here we describe that patients’ blood monocytic cells showed increased expression of CD11b, while HLA-DR expression was decreased compared to healthy controls. The iRBD patients had increased classical monocytes and mature natural killer cells. Remarkably, the levels of expression of Toll-like receptor 4 (TLR4) on blood monocytes in iRBD patients were positively correlated with nigral immune activation measured by 11C-PK11195 PET and negatively correlated with putaminal 18F-DOPA uptake; the opposite was seen for the percentage of CD163+ myeloid cells. This suggesting a deleterious role for TLR4 and, conversely, a protective one for the CD163 expression. We show an association between peripheral blood monocytes and brain immune and dopaminergic changes in a synucleinopathy-related disorder, thus suggesting a cross-talk among periphery and brain during the disease. Significance This study shows that the myeloid immune response in isolated rapid-eye-movement sleep behavior disorder (iRBD) patients involves both brain and periphery, and that these responses are related, supporting a cross-talk between the brain and the peripheral immune system. Furthermore, these immune events were correlated with dopaminergic neuronal changes, strongly supporting a role for the immune system in the neuronal process associated with iRBD and putatively with Parkinson’s disease. These findings support monocytes as biomarkers and potential targets. Future studies should address possible association between monocytic changes and disease progression in longitudinal cohorts and the use of monocytes as accessible prognostic markers of brain events in synucleinopathies.


  • Open Access

    Automatic sleep staging using ear-EEG

    by Kaare B. Mikkelsen, David Bové Villadsen, Marit Otto, Preben Kidmose

    Sleep and sleep quality assessment by means of sleep stage analysis is important for both scientific and clinical applications. Unfortunately, the presently preferred method, polysomnography (PSG), requires considerable expert assistance and significantly affects the sleep of the person under observation. A reliable, accurate and mobile alternative to the PSG would make sleep information much more readily available in a wide range of medical circumstances. Using an already proven method, ear-EEG, in which electrodes are placed inside the concha and ear canal, we measure cerebral activity and automatically score the sleep into up to five stages. These results are compared to manual scoring by trained clinicians, based on a simultaneously recorded PSG. The correspondence between manually scored sleep, based on the PSG, and the automatic labelling, based on ear-EEG data, was evaluated using Cohen’s kappa coefficient. Kappa values are in the range 0.5–0.8, making ear-EEG relevant for both scientific and clinical applications. Furthermore, a sleep-wake classifier with leave-one-out cross validation yielded specificity of 0.94 and sensitivity of 0.52 for the sleep stage. Ear-EEG based scoring has clear advantages when compared to both the PSG and other mobile solutions, such as actigraphs. It is far more mobile, and potentially cheaper than the PSG, and the information on sleep stages is far superior to a wrist-based actigraph, or other devices based solely on body movement. This study shows that ear-EEG recordings carry information about sleep stages, and indicates that automatic sleep staging based on ear-EEG can classify sleep stages with a level of accuracy that makes it relevant for both scientific and clinical sleep assessment.


  • The electrophysiological response to immunoglobulin therapy in chronic inflammatory demyelinating polyneuropathy

    by M. Otto, L. Markvardsen, H. Tankisi, J. Jakobsen, A. Fuglsang-Frederiksen

    To characterize changes in motor nerve conduction studies (MNCS) and motor unit number index (MUNIX) following treatment with subcutaneous immunoglobulin and to assess whether these changes are related to muscle strength. Data from 23 patients participating in a randomized, controlled trial were analyzed. MNCS and MUNIX were performed before and after 12 weeks of treatment. Isokinetic strength (IMS) was measured in various muscles together with grip strength (GS). Proximally evoked compound muscle action potential (CMAP) amplitudes and MUNIX tended to be better preserved in treated patients (P=.049 and .045). Changes in other parameters did not differ between groups. There was no correlation between changes in electrophysiological parameters and IMS. Changes in GS were related to median nerve motor conduction velocity, distal motor latency, CMAP amplitudes, and distally evoked CMAP duration (P=.013–.035). Proximally evoked CMAP amplitudes appear to be the best MNCS parameter to assess treatment outcome in chronic inflammatory demyelinating polyneuropathy.


  • Open Access

    Gastrointestinal motility during sleep assessed by tracking of telemetric capsules combined with polysomnography – a pilot study

    by Anne-Mette Haase, Sibylle Fallet, Marit Otto, Mark S Scott, Vincent Schlageter, Klaus Krogh

    Studies of gastrointestinal function during sleep are hampered by lack of applicable techniques. Recent development of a novel ambulatory telemetric capsule system, which can be used in conjunction with polysomnography, offers a solution to this problem. The 3D-Transit system consists of ingestible electromagnetic capsules traceable through a portable extracorporeal receiver while traversing the gut. During sleep monitored by polysomnography, gastrointestinal motility was concurrently investigated using 3D-Transit in nine healthy subjects. Overall, the amplitude of gastric contractions decreased with depth of sleep (light sleep, N2 versus deep sleep, N3; PPP<0.05) when compared with nocturnal wake periods. In conclusion, the novel ambulatory 3D-Transit system combined with polysomnography allows minimally invasive and completely ambulatory investigation of associations between sleep patterns and gastrointestinal motility.


  • Misinterpretation of sural nerve conduction studies due to anatomical variation

    by Hatice Tankisi, Kirsten Pugdahl, Marit Otto, Anders Fuglsang-Frederiksen